References

  1. Ouedraogo AS, Yameogo JT, Poda GE, Kientega Y, Ouedraogo Traore R. Prevalence of anti-CMV antibodies in blood donors in Ouagadougou (Burkina Faso). Med Sante Trop. 2012 Jan-Mar;22(1):107-9. PubMed | Google Scholar

  2. Adjei AA, Armah HB, Gbagbo F, Boamah I, Adu-Gyamfi C, Asare I. Seroprevalence of HHV-8, CMV, and EBV among the general population in Ghana, West Africa. BMC Infect Dis. 2008 Dec 5;382(1):28-36. PubMed | Google Scholar

  3. Gandhi MK, Khanna R. Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments. Lancet Infect Dis. 2004 Dec;4(12):725-38. PubMed | Google Scholar

  4. Baroco AL, Oldfield EC. Gastrointestinal cytomegalovirus disease in the immunocompromised patient. Curr Gastroenterol Rep. 2008 Aug;10(4):409-16. PubMed | Google Scholar

  5. Roblin X, Pillet S, Oussalah A, Berthelot P, Del Tedesco E, Phelip JM et al. Cytomegalovirus load in inflamed intestinal tissue is predictive of resistance to immunosuppressive therapy in ulcerative colitis. Am J Gastroenterol. 2008 Nov;106(11):2001-8. PubMed | Google Scholar

  6. Domenech E, Vega R, Ojanguren I, Hernandez A, Garcia-Planella E, Bernal I et al. Cytomegalovirus infection in ulcerative colitis: a prospective, comparative study on prevalence and diagnostic strategy. Inflamm Bowel Dis. 2008 Oct;14(10):1373-9. PubMed | Google Scholar

  7. Yan Z, Wang L, Dennis J, Doern C, Baker J, Park JY. Clinical Significance of Isolated Cytomegalovirus-Infected Gastrointestinal Cells. Int J Surg Pathol. 2014 Jun 2; 22(6):492-8. PubMed | Google Scholar

  8. Sahiner F, Honca M, Cekmez Y, Kubar A, Honca T, Fidanci MK et al. The role of maternal screening in diagnosing congenital cytomegalovirus infections in highly immune populations. Ir J Med Sci. 2014 Jun 4;184(2):475-81. PubMed | Google Scholar

  9. Hertel L. Human cytomegalovirus tropism for mucosal myeloid dendritic cells. Rev Med Virol. 2014 Nov;24(6):379-95. PubMed | Google Scholar

  10. Biggar RJ, Henle W, Fleisher G, Bocker J, Lennette ET, Henle G. Primary Epstein-Barr virus infections in African infants I: decline of maternal antibodies and time of infection. Int J Cancer. 1978 Sep 15;22(3):239-43. PubMed | Google Scholar

  11. Macsween KF, Crawford DH. Epstein-Barr virus-recent advances. Lancet Infect Dis. 2003 Mar;3(3):131-40. PubMed | Google Scholar

  12. Sarmati L. HHV-8 infection in African children. Herpes. 2004 Aug;11(2):50-3. PubMed | Google Scholar

  13. Salahuddin SZ, Ablashi DV, Markham PD, Josephs SF, Sturzenegger S, Kaplan M et al. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science. 1986 Oct 31;234(4776):596-601. PubMed | Google Scholar

  14. Di Luca D, Mirandola P, Ravaioli T, Bigoni B, Cassai E. Distribution of HHV-6 variants in human tissues. Infect Agents Dis. 1996 Oct;5(4):203-14. PubMed | Google Scholar

  15. van Baarle D, Hovenkamp E, Callan MF, Wolthers KC, Kostense S, Tan LC et al. Dysfunctional Epstein-Barr virus (EBV)-specific CD8(+) T lymphocytes and increased EBV load in HIV-1 infected individuals progressing to AIDS-related non-Hodgkin lymphoma. Blood. 2001 Jul 1;98(1):146-55. PubMed | Google Scholar

  16. Epstein MA, Achong BG, Barr YM. Virus Particles in Cultured Lymphoblasts from Burkitt's Lymphoma. Lancet. 1964 Mar 28;1(7335):702-3. PubMed | Google Scholar

  17. Ferrari D, Codeca C, Bertuzzi C, Broggio F, Crepaldi F, Luciani A et al. Role of plasma EBV DNA levels in predicting recurrence of nasopharyngeal carcinoma in a Western population. BMC Cancer. 2012;12(1):208. PubMed | Google Scholar

  18. Zhang T, Fu Q, Gao D, Ge L, Sun L, Zhai Q. EBV associated lymphomas in 2008 WHO classification. Pathol Res Pract. 2014 Feb;210(2):69-73. PubMed | Google Scholar

  19. Dangou JM, Sambo BH, Moeti M, Diarra-Nama A-J. Cancer prevention and control in the WHO African region: a plea for action. J Afr Cancer. 2009;1(1):56-60. PubMed | Google Scholar

  20. Tao I, Bisseye C, Nagalo BM, Sanou M, Kiba A, Surat G et al. Screening of Hepatitis G and Epstein-Barr Viruses Among Voluntary non Remunerated Blood Donors (VNRBD) in Burkina Faso, West Africa. Mediterr J Hematol Infect Dis. 2013;5(1):e2013053. PubMed | Google Scholar

  21. Furui Y, Satake M, Hoshi Y, Uchida S, Suzuki K, Tadokoro K. Cytomegalovirus (CMV) seroprevalence in Japanese blood donors and high detection frequency of CMV DNA in elderly donors. Transfusion. 2013 Oct;53(10):2190-7. PubMed | Google Scholar

  22. Kothari A, Ramachandran VG, Gupta P, Singh B, Talwar V. Seroprevalence of cytomegalovirus among voluntary blood donors in Delhi, India. J Health Popul Nutr. 2002 Dec;20(4):348-51. PubMed | Google Scholar

  23. Adjei A, Armah H, Narter-Olaga E. Seroprevalence of cytomegalovirus among some voluntary blood donors at the 37 military hospital, accra, ghana. Ghana Med J. 2006 Sep;40(3):99-104. PubMed | Google Scholar

  24. Kumar H, Gupta PK, Kumar S, Sarkar RS. Is seroprevalence of anti-IGM CMV among blood donors relevant in India. Indian J Pathol Microbiol. 2008 Jul-Sep;51(3):351-2. PubMed | Google Scholar

  25. Kabyemera R, Masalu N, Rambau P, Kamugisha E, Kidenya B, De Rossi A et al. Relationship between non-Hodgkin's lymphoma and blood levels of Epstein-Barr virus in children in north-western Tanzania: a case control study. BMC Pediatr. 2013;13:4. PubMed | Google Scholar

  26. Wang X, Yang K, Wei C, Huang Y, Zhao D. Coinfection with EBV/CMV and other respiratory agents in children with suspected infectious mononucleosis. Virol J. 2010 Aug;21(2):251-64. PubMed | Google Scholar